Octarine Bio ApS: Financial statements 2021
CVR: 39857316
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Octarine Bio ApS (CVR 39857316) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 1,681,548 and a net result of DKK -6,418,626 compared with DKK -2,372,514 the year before. That is an increase of 83.4% compared with the year before. Equity in the 2021 report amounted to DKK 6,526,535. The solvency ratio was 44.5%. The company had 7 employees in the financial year.
- Gross Profit
- DKK 1,681,548
- Profit/Loss
- DKK -6,418,626
- Equity
- DKK 6,526,535
- Total Assets
- DKK 14,675,934
- Employees
- 7
Official annual report
Find more companies like Octarine Bio ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
As of December 15, 2021, Akshat Kshetrapal has joined the board of directors of Octarine Bio ApS.
Octarine Bio ApS has published its annual report for 2020. Gross profit came to DKK 916,667, and the net result was DKK -2,372,514.
As of March 5, 2021, Lene Gerlach has joined the board of directors of Octarine Bio ApS.
About Octarine Bio ApS
Octarine Bio ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2018. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Octarine Bio IVS. The management consists of Nethaji Janeshawari Gallage and Nicholas Stuart William Milne. The board consists of Stephan Christgau (chair), Akshat Kshetrapal, Alexandre Ouimet-Storrs and Anna Søndergaard. The company's owners include Nicholas Stuart William Milne, Biosphere ApS and UV Fund I K/S. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 1,715,333 and a net result of DKK -11,501,321 compared with DKK -22,298,751 the year before. Equity in the 2025 report amounted to DKK 31,907,827.